This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03295/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03295/identifier/kegg-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03295/identifier/pubchem-compound/
n15http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB03295/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03295/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03295/identifier/chebi/

Statements

Subject Item
n2:DB03295
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n14:DB03295 n15:DB03295
dcterms:title
Glutathionylspermidine
adms:identifier
n6:46936634 n7:46505567 n8:C05730 n9:TS5 n11:16613 n12:DB03295
n3:IUPAC-Name
n4:271B61EB-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B61F1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B61F0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B61ED-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B61EE-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B61EF-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B61E9-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B61E7-363D-11E5-9242-09173F13E4C5 n4:271B61EA-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B61E8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B61F7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B61F8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B61F2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B61F3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B61F5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B61F4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B61F6-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B61FD-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B61FF-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6200-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B61FC-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B61FB-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B61FE-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B61EC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B61F9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B61FA-363D-11E5-9242-09173F13E4C5